27,380 Alzheimer's and dementia studies in plain English, each scored out of 100.
Alzheimer's Disease (AD) remains a significant global health challenge, characterized by progressive neurodegeneration and a decline in cognitive abilities such as memory and learning. 4 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
A 52-year-old male with early-stage Alzheimer's disease and long-standing anxiety received 30 repetitive transcranial magnetic stimulation sessions over 8 months and 20-month Mediterranean diet intervention. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
The results showed that the experimental group had a statistically significant difference of attention (TMT-B) and working memory scores, while the control group had no statistically significant difference for both attention and working memory. 3 key findings →
Participants: 13 Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Instrumental assessments (Videofluoroscopic Swallowing Study [VFSS], Fiberoptic Endoscopic Evaluation of Swallowing [FEES]) and the Water Swallow Test were most frequently used.ICF mapping revealed that 96.7% of tools focused on body functions, while only approximately 20% addressed participation and environmental factors. 2 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
We created and hosted a dementia workshop for first and second year medical students in 2023 and 2024 aimed at increasing interest and passion for empathic dementia care. 1 key finding →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
The logic model and summary results explain in detail how this dementia palliative care service undertook activities relating to person-centred care, carer support, end-of-life care, accessible care, timely care, and integrated care. 3 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
This has meant that fewer people are dying as a direct result of HIV, and the life expectancy for people living with HIV is almost the same as the general population in many countries. 2 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Population ageing, multi-morbidity and associated disability is shifting global demand for health and care services. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
This study explored the views and experiences of Australians living with dementia relating to voluntary assisted dying (VAD) as an end-of-life care option. 2 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
By combining AI-assisted topic modelling and community engagement, this study aimed to advance the research landscape for Lewy body dementia (LBD). 1 key finding →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Advance care planning (ACP) in dementia has been defined as a communication process adapted to the person’s capacity, which includes, and is continued with family, in our European Association for Palliative Care Delphi study Delphi study with an expert panel from 33 countries. 2 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
For people with dementia (n = 6), readiness was facilitated by a desire for autonomy. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
The overall advance care planning behavioural intention was at a moderately high level. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Appendix B. Coding tree of main categories and specific sub categories describing factors influencing readiness for advance care planning among people with dementia, family caregivers, and healthcare professionals. 2 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Three types emerged from 24 caregivers through a Varimax rotation and explained 53% of the total variance. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Appendix A. Interview guides on experiences with advance care planning, factors influencing readiness for advance care planning, and the use of conversation aids among people with dementia, family caregivers, and healthcare professionals. 2 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Palliative care should be introduced as a culturally tailored set of services to assist families in ways that align with their values and caregiving practices. 1 key finding →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Antecedents of acute care use and poor prognosis may suggest late utilization of palliative care among PLWD and lack of palliative care needs screening. 1 key finding →
Participants: 16 Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
These dysregulations are associated with malfunctions in multiple signaling pathways or disrupted mechanical cellular responses. 1 key finding →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
OCTA is a handy, noninvasive tool that enables the visualization of diminished retinal microvascular density in cases of early CSVD. 3 key findings →
Participants: 40 Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Stroke is the leading cause of acquired disability. 2 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
In medical school, students learn to view the world through a biomedical lens. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
The recent approval of disease-modifying therapies (DMTs) for early Alzheimer's disease (AD) marks a major shift in clinical practice. 5 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
In this update, we discuss the use of real-world data in the Haute Autorité de Santé assessment of economic evaluations, review how real-world evidence is supporting regulatory approvals in multiple myeloma, and consider lessons from the failed EVOKE trials of semaglutide in Alzheimer's disease for the broader application of target trial emulation. 1 key finding →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Dementias are expensive diseases: the net annual cost in European healthcare is about € 28.000 per case with a strong stage dependency, of which medical care accounts for about 19%. 2 key findings →
Evidence: low
Full summary, score breakdown and related studies → Original source Free full text
Free full text links and the Full text may need a subscription label come from Unpaywall, Europe PMC and OpenAlex records of free copies, checked 10 Oct 2026. A study with neither is unknown, not paywalled.
This is alzhub's own score. It is not an official metric, not an impact factor, and no journal, publisher or ranking body endorses it. We built it so that a reader who is not a scientist can tell a landmark trial from a conference abstract without having to already know the difference. Every point comes from one of 20 components, all of them printed on the study itself, so you can disagree with our arithmetic rather than having to trust the total.
Journals are placed in ordered tiers, never given a numeric impact factor — we could not verify current impact factors from a source we control, and an invented one would be worse than none. Tier 1 is the top-tier general journals (NEJM, The Lancet, JAMA, Nature, Science, Nature Medicine); tier 2 is the leading specialty journals; tier 3 is every other peer-reviewed journal. A separate part scores how much the journal's own papers are cited, which tells the tier-3 journals apart.
Two rules we don't bend. First, we never fill in a missing value: if a record does not state a sample size or a design, that component scores zero, and if we simply have no data for a part, such as a citation count, that part is left out and the study is scored on the parts we could check. The study card says which. Second, anything that is not a peer-reviewed article is capped at 16/100 and carries a warning chip — so a conference abstract or a company press release can never outrank a peer-reviewed paper, no matter how good it looks.
We rank a rigorous null result — a good trial showing that something does not work — above an early positive finding. Someone deciding whether to buy a supplement is served by that, and the rigour is already counted by the design and journal components.
The score is computed from the published data alone and is reproducible: the same file always yields the same numbers.
See the whole rubric drawn out → — four charts covering all 27,380 studies: how the scores are spread and where the cap bites, which of the 20 components the library is strong and weak on, which subjects rest on stronger evidence, and what kinds of study each subject is actually built from.
This is a large sample of the Alzheimer's literature, not an exhaustive index of it. It holds 27,380 records, built mostly from automated pulls of Europe PMC (60.6% of the library) and OpenAlex (18.6%), plus smaller pulls from PubMed, Crossref and medRxiv. If a study, a drug, or a finding isn't here, that is not evidence it doesn't exist in the literature — it may simply not have been pulled in yet.
1,032 records (3.8% of the library) are not peer-reviewed — 962 of those are preprints posted before any journal review, and the rest are conference abstracts, regulatory notices and reports. Every study card on this page states its status plainly, and the score above is capped for anything that isn't a peer-reviewed article.
See the full, machine-readable breakdown of this library's coverage →